Inh and Tylenol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Inh (isoniazid) and Tylenol (acetaminophen). Common drug interactions include nausea among females and arthropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Inh and Tylenol. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Inh?

Inh has active ingredients of isoniazid. It is often used in latent tuberculosis. eHealthMe is studying from 646 Inh users. Check the latest studies of Inh.

What is Tylenol?

Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,309 Tylenol users. Check the latest studies of Tylenol.



On Jul, 16, 2026

40 people who take Inh and Tylenol together, and have interactions are studied.

Inh and Tylenol drug interactions.

What are the common drug interactions of Inh and Tylenol, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Neck pain
  3. Neoplasm malignant (cancer tumour)
  4. Neoplasm progression (growth of tumour)
  5. Oropharyngeal pain
  6. Pain in jaw
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Pneumonia

male:

  1. Arthropathy
  2. Blood pressure systolic increased
  3. International normalised ratio increased
  4. Activated partial thromboplastin time prolonged
  5. Aspartate aminotransferase increased
  6. Bk virus infection
  7. Blood albumin decreased
  8. Blood alkaline phosphatase increased
  9. Blood calcium decreased
  10. Blood magnesium increased

What are the common drug interactions of Inh and Tylenol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Acute leukaemia (blood cancer)
  4. Blast crisis in myelogenous leukaemia
  5. Bone pain
  6. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  7. Death
  8. Haemorrhage (bleeding)
  9. Leukostasis (excessive number of white blood cells in blood)
  10. Neoplasm malignant (cancer tumour)

40-49:

n/a

50-59:

  1. Renal tubular atrophy (wasting of kidney tubules)
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  4. International normalised ratio increased
  5. Activated partial thromboplastin time prolonged
  6. Aspartate aminotransferase increased
  7. Bk virus infection
  8. Blood albumin decreased
  9. Blood alkaline phosphatase increased
  10. Blood calcium decreased

60+:

  1. Fatigue (feeling of tiredness)
  2. Breast abscess
  3. Heart rate decreased
  4. Tooth infection
  5. Adverse event
  6. Blood pressure inadequately controlled
  7. Blood pressure increased
  8. Injection site pain
  9. Tooth disorder (tooth disease)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 31 people, 77.50%
  2. High Blood Pressure: 15 people, 37.50%
  3. Blood Pressure Abnormal: 5 people, 12.50%
  4. Hypercoagulation (increased tendency for clotting of the blood): 2 people, 5.00%
  5. Asthma: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Inh and Tylenol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Inh and Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Inh:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Inh and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tylenol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on isoniazid and acetaminophen (the active ingredients of Inh and Tylenol, respectively), and Inh and Tylenol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: